Highlights:

• Pathophysiology, clinical presentation, classification and diagnostic criteria
• Review of treatment options and managing associated co-morbidities
• ESC guidelines on heart failure
• Update on ARNI (sacubitril/valsartan) new treatment option
• Role of SGLT2 inhibitors in heart failure and T2D

Speaker

Dr Saqib Mahmud
FRCP(Edin); FRCP(Glasg); FRCP(London); FRCGP
Primary care physician, GP trainer and GPwSI in Diabetes and Cardiology

Chairperson

Dr Jane Wilcock
BSc MBChB FRCGP PGCertMedEd, MA HEd and SF HEA
GP, Clinical advisor RCGP, Chair overdiagnosis group RCGP, Vicechair NWE faculty RCGP

Awarded 1 CPD Credit